Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

Literature DB >> 17055126

Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

Haroldo Toro¹, De-chu C Tang, David L Suarez, Matt J Sylte, Jennifer Pfeiffer, Kent R Van Kampen.

Abstract

Protective immunity against avian influenza virus was elicited in chickens by single-dose in ovo vaccination with a non-replicating human adenovirus vector encoding an H5N9 avian influenza virus hemagglutinin. Vaccinated chickens were protected against both H5N1 (89% hemagglutinin homology; 68% protection) and H5N2 (94% hemagglutinin homology; 100% protection) highly pathogenic avian influenza virus challenges. This vaccine can be mass-administered using available robotic in ovo injectors which provide a major advantage over current vaccination regimens. In addition, this class of adenovirus-vectored vaccines can be produced rapidly with improved safety since they do not contain any replication-competent adenoviruses. Furthermore, this mode of vaccination is compatible with epidemiological surveys of natural avian influenza virus infections.

Entities: Disease Species

Mesh：

Substances：

Year: 2006 PMID： 17055126 PMCID： PMC2736859 DOI： 10.1016/j.vaccine.2006.09.047

Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641

26 in total

1. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.

Authors: Wentao Gao; Adam C Soloff; Xiuhua Lu; Angela Montecalvo; Doan C Nguyen; Yumi Matsuoka; Paul D Robbins; David E Swayne; Ruben O Donis; Jacqueline M Katz; Simon M Barratt-Boyes; Andrea Gambotto
Journal: J Virol Date: 2006-02 Impact factor: 5.103

2. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.

Authors: Elodie Ghedin; Naomi A Sengamalay; Martin Shumway; Jennifer Zaborsky; Tamara Feldblyum; Vik Subbu; David J Spiro; Jeff Sitz; Hean Koo; Pavel Bolotov; Dmitry Dernovoy; Tatiana Tatusova; Yiming Bao; Kirsten St George; Jill Taylor; David J Lipman; Claire M Fraser; Jeffery K Taubenberger; Steven L Salzberg
Journal: Nature Date: 2005-10-05 Impact factor: 49.962

3. A simplified system for generating recombinant adenoviruses.

Authors: T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal: Proc Natl Acad Sci U S A Date: 1998-03-03 Impact factor: 11.205

4. Serotype specificity of adenovirus purification using anion-exchange chromatography.

Authors: John O Konz; Rebecca C Livingood; Andrew J Bett; Aaron R Goerke; Michael E Laska; Sangeetha L Sagar
Journal: Hum Gene Ther Date: 2005-11 Impact factor: 5.695

5. Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines.

Authors: J A Lewis; E L Brown; P A Duncan
Journal: Dev Biol (Basel) Date: 2006

6. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.

Authors: H Stone; B Mitchell; M Brugh
Journal: Avian Dis Date: 1997 Oct-Dec Impact factor: 1.577

7. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector.

Authors: J Zhu; M Grace; J Casale; A T Chang; M L Musco; R Bordens; R Greenberg; E Schaefer; S R Indelicato
Journal: Hum Gene Ther Date: 1999-01-01 Impact factor: 5.695

8. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

Authors: Kent R Van Kampen; Zhongkai Shi; Peng Gao; Jianfeng Zhang; K Wade Foster; Dung-Tsa Chen; Donald Marks; Craig A Elmets; De-chu C Tang
Journal: Vaccine Date: 2005-01-11 Impact factor: 3.641

9. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

Authors: Mary A Hoelscher; Sanjay Garg; Dinesh S Bangari; Jessica A Belser; Xiuhua Lu; Iain Stephenson; Rick A Bright; Jacqueline M Katz; Suresh K Mittal; Suryaprakash Sambhara
Journal: Lancet Date: 2006-02-11 Impact factor: 79.321

10. Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act.

Authors: Anthony S Fauci
Journal: Cell Date: 2006-02-24 Impact factor: 41.582

27 in total

1. Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1.

Authors: Zhisheng Wang; Qinghua Yu; Junkai Gao; Qian Yang
Journal: Clin Vaccine Immunol Date: 2011-11-30

Review 2. Progress on adenovirus-vectored universal influenza vaccines.

Authors: Kui Xiang; Guan Ying; Zhou Yan; Yan Shanshan; Zhang Lei; Li Hongjun; Sun Maosheng
Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452

3. Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5.

Authors: Haroldo Toro; Frederik W van Ginkel; De-Chu C Tang; Bettina Schemera; Soren Rodning; Joseph Newton
Journal: Avian Dis Date: 2010-03 Impact factor: 1.577

4. Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.

Authors: Shailbala Singh; Haroldo Toro; De-Chu Tang; Worthie E Briles; Linda M Yates; Renee T Kopulos; Ellen W Collisson
Journal: Virology Date: 2010-06-16 Impact factor: 3.616

5. Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine.

Authors: Haroldo Toro; De-chu C Tang; David L Suarez; Jianfeng Zhang; Zhongkai Shi
Journal: Vaccine Date: 2008-03-17 Impact factor: 3.641

6. Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses.

Authors: Alaina J Mooney; S Mark Tompkins
Journal: Future Virol Date: 2013-01-01 Impact factor: 1.831

7. The prevention and control of avian influenza: the avian influenza coordinated agriculture project.

Authors: C Cardona; R Slemons; D Perez
Journal: Poult Sci Date: 2009-04 Impact factor: 3.352

8. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.

Authors: Haichen Song; Gloria Ramirez Nieto; Daniel R Perez
Journal: J Virol Date: 2007-06-27 Impact factor: 5.103

Review 9. Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.

Authors: De-chu C Tang; Jianfeng Zhang; Haroldo Toro; Zhongkai Shi; Kent R Van Kampen
Journal: Expert Rev Vaccines Date: 2009-04 Impact factor: 5.217

10. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.

Authors: Baibaswata Nayak; Subrat N Rout; Sachin Kumar; Mohammed S Khalil; Moustafa M Fouda; Luay E Ahmed; Kenneth C Earhart; Daniel R Perez; Peter L Collins; Siba K Samal
Journal: PLoS One Date: 2009-08-05 Impact factor: 3.240